DM conflict of interest
posted on
Nov 09, 2023 02:00AM
DM may have a conflict of interest here
First, thank you responding to my earlier post. Very enlighting for me and the many, many others who visit the hub but do not post. A thank you from those in this hub.
I have a great respect to those following this hub. Personally, thanks.
Now, believe DM has a conflict of interest in his position of CEO of both RVX and ZEN. Ouch, damn if he does and damn is he does not. Some may say this would be a Board decision, so where has the Board been in the last ten years. BOM, why would Board allow the test to include unknown results. BOM should have been limited to increasing HDL and reducing Type II.
Does DM sell short (causing harm to Z shareholders) to gather funds from sale of ZEN to fund RVX, or keep ZEN long and let RVX die? Either way spells trouble. With FDA approval, Z stock price increases quickly, real value to shareholder. Little value selling short.
Please help, the discussion appears there is some hope for RVX, very doubtful for me at this time. Appears ZEN will bail RVX out. Not sure how that would work, only instant cash appears to work.
Long term royalties, no way, DM could just squander never receiving sufficient funds to complete a P3 required by FDA. His track record is not positive in managing a small pharma. Option, he may receive a loan with the security of the future proceeds of a royalty. But that requires FDA approval, still seems years away and a great risk with the lending institution. A future promise, high interest rates equals hard money lending.
Funding is the big issue, so why keep RVX. Is there no market from the big boys in Apabetalone and the other potential formulas? I doubt this, big boys are cash heavy. Even a 50/50 cash/stock acquisition would be great. So what is the problem? DM could sell the RVX assets, keep possible Z royalties.
I have been in the game for many years and own too many ZEN’s. How close is ZEN to the finish line? ZEN’s test results have shown very positive results in extending life. Surely the FDA knows. Are we looking at 2, 3 4 years?
How close are we?
Very frustrating,
Thanks, sidebar